NEC to create a global innovation base near Tokyo

TOKYO, Nov 28, 2022 - (JCN Newswire via SEAPRWire.com) - NEC Corporation has announced the construction of a global base for innovation near Tokyo. The provisionally named "NEC Innovation Building" is slated to be 12 stories above ground and to provide a total floor area of approximately 50,000 square meters...

Consortium of Japan partners successfully promote domestic production and cost reduction for 5G core technology, the basis for next-generation communication standards

TOKYO, Nov 24, 2022 - (JCN Newswire via SEAPRWire.com) - The University of Tokyo, Internet Initiative Japan (IIJ), APRESIA, and Fujitsu Limited have successfully developed Open Source Software for the Private 5G/6G Mobile System, realizing a domestically produced, low-cost 5G core network (5GC), the core technology of the 5G mobile...

To Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research

TOKYO, Nov 22, 2022 - (JCN Newswire via SEAPRWire.com) - Shimadzu Corporation (Shimadzu), Eisai Co., Ltd. (Eisai), Oita University, and Usuki City Medical Association hereby announce the commencement of a cohort study using Usuki City as a demonstration site. This joint study will attempt to develop Japan's first diagnostic workflow...

NTT DOCOMO and SK Telecom to Collaborate on Technological Advancement of Metaverse, Digital Media and 5G/6G

TOKYO, Nov 21, 2022 - (JCN Newswire via SEAPRWire.com) - NTT DOCOMO, INC. announced today that it has agreed with leading Korean telecommunications operator SK Telecom (SKT) to collaborate on the competitive enhancement of their respective smart-life businesses and communications-infrastructure technologies worldwide.In the smart-life field, DOCOMO and SKT will discuss...

Eisai to Present Full Findings from Lecanemab Confirmatory Phase 3 Clinical Trial (Clarity AD) and Other Alzheimer’s Disease Research at The 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

TOKYO, Nov 21, 2022 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. will present the efficacy, safety and biomarker findings from the company's Phase 3 confirmatory Clarity AD clinical trial for lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the potential treatment of mild cognitive...

Fujitsu and Wakayama Medical University start joint trials for millimeter-wave sensor to detect falls of elderly patients

TOKYO, Nov 21, 2022 - (JCN Newswire via SEAPRWire.com) - Fujitsu and Wakayama Medical University today announced the start of joint trials of a technology to support nurses and caregivers in visually monitoring patients in privacy-sensitive contexts, including hospital rooms and nursing facilities. The technology leverages Fujitsu's technique for accurately...